Browsing Tag
NYSE
98 posts
BP (LSE: BP.) investor roadmap: What retail investors need to watch before the April 28 results
BP will release Q1 2026 results on April 28 under new CEO Meg O'Neill. Here is the full retail investor roadmap covering the reset strategy, Castrol sale, debt targets, and what to watch on the call.
Wipro (WIT) secures eight-year, $1bn Olam contract and pays $375m for agribusiness IT unit Mindsprint
Wipro secures an $1bn, eight-year Olam Group transformation deal and acquires Mindsprint for $375m. What it means for WIT stock, competitors, and agribusiness IT. Read more.
Molson Coors closes Monaco Cocktails deal, enters top five in U.S. ready-to-drink segment
Molson Coors (TAP) completes acquisition of Monaco Cocktails, entering the top five U.S. RTD suppliers. What the deal means for strategy, competitors, and investors. Read more.
KGS near 52-week high as Kodiak Gas Services completes distributed power pivot with DPS acquisition at $587m cash
Kodiak Gas Services (KGS) closes $587m DPS acquisition, launching Kodiak Power Solutions with 395MW for data centers and microgrids. Read the full analysis.
IBM and ETH Zurich launch 10-year algorithm research initiative for the AI and quantum era
IBM and ETH Zurich launch a 10-year algorithm research initiative for AI and quantum computing. Read what this means for enterprise tech strategy.
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
Infosys to acquire Optimum Healthcare IT for $465M to lead AI-driven US health system transformation. Read the full strategic and market analysis.
Abbott (ABT) closes $21bn Exact Sciences deal, making it the leader in U.S. cancer screening diagnostics
Abbott (ABT) closes its $21bn Exact Sciences acquisition, creating a $12bn+ diagnostics leader in cancer screening and precision oncology. Read the full analysis.
Woodside Energy (ASX, NYSE: WDS) confirms Liz Westcott as CEO in bet on operational delivery over commercial ambition
Woodside Energy (ASX: WDS) appoints Liz Westcott as permanent CEO. What it means for Scarborough LNG, shareholder returns, and the LNG sector. Read more.
GSK to sell linerixibat rights to Alfasigma for up to $690m as rare liver disease drug nears FDA approval
GSK and Alfasigma agree worldwide licence for linerixibat, a rare liver disease itch drug nearing FDA approval. Deal worth up to $690 million. Read more.
Target Corporation (NYSE: TGT) bets $2bn on retail reset as FY 2025 earnings disappoint but guidance lifts the stock
Target (TGT) posts Q4 2025 adjusted EPS of $2.44, beats estimates, and unveils a $2 billion reset plan. Read what it means for investors.